{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:50:12Z","timestamp":1792817412052,"version":"4.5.0"},"reference-count":58,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,7,7]]},"abstract":"<jats:title>Key Points<\/jats:title><jats:p>Survival was 100% for 18 patients with ADA-SCID treated with genetically modified CD34+ cells (2.3-13.4 years follow up; median, 6.9 years). Long-term engraftment, immune reconstitution, and fewer severe infections were observed in 15 out of 18 patients without leukemic transformation.<\/jats:p>","DOI":"10.1182\/blood-2016-01-688226","type":"journal-article","created":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T03:43:07Z","timestamp":1461987787000},"page":"45-54","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":201,"title":["Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency"],"prefix":"10.1182","volume":"128","author":[{"given":"Maria Pia","family":"Cicalese","sequence":"first","affiliation":[{"name":"San Raffaele Telethon Institute for Gene Therapy, San Raffaele Scientific Institute, Milan, Italy;"},{"name":"Pediatric Immunohematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Ferrua","sequence":"additional","affiliation":[{"name":"San Raffaele Telethon Institute for Gene Therapy, San Raffaele Scientific Institute, Milan, Italy;"},{"name":"Pediatric Immunohematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy;"},{"name":"Vita-Salute San Raffaele University, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Castagnaro","sequence":"additional","affiliation":[{"name":"San Raffaele Telethon Institute for Gene Therapy, San Raffaele Scientific Institute, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Pajno","sequence":"additional","affiliation":[{"name":"Pediatric Immunohematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy;"},{"name":"Vita-Salute San Raffaele University, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Barzaghi","sequence":"additional","affiliation":[{"name":"San Raffaele Telethon Institute for Gene Therapy, San Raffaele Scientific Institute, Milan, Italy;"},{"name":"Pediatric Immunohematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Giannelli","sequence":"additional","affiliation":[{"name":"San Raffaele Telethon Institute for Gene Therapy, San Raffaele Scientific Institute, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Dionisio","sequence":"additional","affiliation":[{"name":"San Raffaele Telethon Institute for Gene Therapy, San Raffaele Scientific Institute, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Immacolata","family":"Brigida","sequence":"additional","affiliation":[{"name":"San Raffaele Telethon Institute for Gene Therapy, San Raffaele Scientific Institute, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Bonopane","sequence":"additional","affiliation":[{"name":"San Raffaele Telethon Institute for Gene Therapy, San Raffaele Scientific Institute, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Casiraghi","sequence":"additional","affiliation":[{"name":"San Raffaele Telethon Institute for Gene Therapy, San Raffaele Scientific Institute, Milan, Italy;"},{"name":"Pediatric Immunohematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Tabucchi","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnology, University of Siena, Siena, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Carlucci","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnology, University of Siena, Siena, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyal","family":"Grunebaum","sequence":"additional","affiliation":[{"name":"Division of Immunology and Allergy, The Hospital for Sick Children, Toronto, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Adeli","sequence":"additional","affiliation":[{"name":"Division of Immunology and Allergy, Hamad Medical Corporation, Doha, Qatar;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robbert G.","family":"Bredius","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"Puck","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of California\u2013San Francisco, San Francisco, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polina","family":"Stepensky","sequence":"additional","affiliation":[{"name":"Pediatric Hematology-Oncology and Bone Marrow Transplantation, Hadassah Hebrew University Hospital, Jerusalem, Israel;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilhan","family":"Tezcan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Section of Pediatric Immunology, Hacettepe University Faculty of Medicine, Ankara, Turkey;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Rolfe","sequence":"additional","affiliation":[{"name":"GSK Research and Development, GlaxoSmithKline, Stevenage, United Kingdom, and Upper Merion, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"De Boever","sequence":"additional","affiliation":[{"name":"GSK Research and Development, GlaxoSmithKline, Stevenage, United Kingdom, and Upper Merion, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rickey R.","family":"Reinhardt","sequence":"additional","affiliation":[{"name":"GSK Research and Development, GlaxoSmithKline, Stevenage, United Kingdom, and Upper Merion, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Appleby","sequence":"additional","affiliation":[{"name":"GSK Research and Development, GlaxoSmithKline, Stevenage, United Kingdom, and Upper Merion, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Ciceri","sequence":"additional","affiliation":[{"name":"Vita-Salute San Raffaele University, Milan, Italy;"},{"name":"Hematology and Bone Marrow Transplant Unit, San Raffaele Scientific Institute, Milan, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Roncarolo","sequence":"additional","affiliation":[{"name":"San Raffaele Telethon Institute for Gene Therapy, San Raffaele Scientific Institute, Milan, Italy;"},{"name":"Vita-Salute San Raffaele University, Milan, Italy;"},{"name":"Department of Pediatrics Division of Stem Cell Transplantation and Regenerative Medicine, and"},{"name":"Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5398-1717","authenticated-orcid":false,"given":"Alessandro","family":"Aiuti","sequence":"additional","affiliation":[{"name":"San Raffaele Telethon Institute for Gene Therapy, San Raffaele Scientific Institute, Milan, Italy;"},{"name":"Pediatric Immunohematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy;"},{"name":"Vita-Salute San Raffaele University, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111905014812700_B1","article-title":"Immunodeficiency disease due to deficiency of adenosine deaminase.","volume-title":"Primary Immunodeficiency Diseases","author":"Hirschhorn","year":"1999"},{"issue":"8","key":"2019111905014812700_B2","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s10875-015-0201-1","article-title":"Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency 2015.","volume":"35","author":"Picard","year":"2015","journal-title":"J Clin Immunol"},{"issue":"17","key":"2019111905014812700_B3","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1182\/blood-2009-06-189209","article-title":"How I treat ADA deficiency.","volume":"114","author":"Gaspar","year":"2009","journal-title":"Blood"},{"issue":"21","key":"2019111905014812700_B4","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1056\/NEJM199605233342104","article-title":"Brief report: hepatic dysfunction as a complication of adenosine deaminase deficiency.","volume":"334","author":"Bollinger","year":"1996","journal-title":"N Engl J Med"},{"issue":"6","key":"2019111905014812700_B5","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/BF00916954","article-title":"Primary immunodeficiencies in Switzerland: first report of the national registry in adults and children.","volume":"8","author":"Ryser","year":"1988","journal-title":"J Clin Immunol"},{"issue":"4","key":"2019111905014812700_B6","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1399-3038.2007.00646.x","article-title":"Severe combined immunodeficiency: a national surveillance study.","volume":"19","author":"Yee","year":"2008","journal-title":"Pediatr Allergy Immunol"},{"issue":"1","key":"2019111905014812700_B7","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s10875-011-9609-4","article-title":"Newborn screening for severe combined immunodeficiency; the Wisconsin experience (2008-2011).","volume":"32","author":"Verbsky","year":"2012","journal-title":"J Clin Immunol"},{"issue":"3","key":"2019111905014812700_B8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10875-014-0006-7","article-title":"Newborn screening for SCID in New York State: experience from the first two years.","volume":"34","author":"Vogel","year":"2014","journal-title":"J Clin Immunol"},{"key":"2019111905014812700_B9","doi-asserted-by":"crossref","DOI":"10.1093\/med\/9780195389838.003.0014","article-title":"Immunodeficiency due to defects of purine metabolism.","volume-title":"Primary immunodeficiency diseases: a molecular and genetic approach","author":"Hirschhorn"},{"issue":"17","key":"2019111905014812700_B10","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1182\/blood-2011-12-396879","article-title":"Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency.","volume":"120","author":"Hassan","year":"2012","journal-title":"Blood"},{"issue":"10","key":"2019111905014812700_B11","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJM198703053161005","article-title":"Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase.","volume":"316","author":"Hershfield","year":"1987","journal-title":"N Engl J Med"},{"issue":"3 Pt 2","key":"2019111905014812700_B12","doi-asserted-by":"crossref","first-page":"S228","DOI":"10.1016\/S0090-1229(95)90306-2","article-title":"PEG-ADA replacement therapy for adenosine deaminase deficiency: an update after 8.5 years.","volume":"76","author":"Hershfield","year":"1995","journal-title":"Clin Immunol Immunopathol"},{"issue":"2","key":"2019111905014812700_B13","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1172\/JCI116626","article-title":"T lymphocyte ontogeny in adenosine deaminase-deficient severe combined immune deficiency after treatment with polyethylene glycol-modified adenosine deaminase.","volume":"92","author":"Weinberg","year":"1993","journal-title":"J Clin Invest"},{"issue":"2","key":"2019111905014812700_B14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.clim.2005.07.006","article-title":"Long-term efficacy of enzyme replacement therapy for adenosine deaminase (ADA)-deficient severe combined immunodeficiency (SCID).","volume":"117","author":"Chan","year":"2005","journal-title":"Clin Immunol"},{"issue":"7","key":"2019111905014812700_B15","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/s10875-015-0191-z","article-title":"Diagnosis, treatment, and long-term follow-up of patients with ADA deficiency: a single-center experience.","volume":"35","author":"Baffelli","year":"2015","journal-title":"J Clin Immunol"},{"issue":"5577","key":"2019111905014812700_B16","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1126\/science.1070104","article-title":"Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning.","volume":"296","author":"Aiuti","year":"2002","journal-title":"Science"},{"issue":"5","key":"2019111905014812700_B17","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJMoa0805817","article-title":"Gene therapy for immunodeficiency due to adenosine deaminase deficiency.","volume":"360","author":"Aiuti","year":"2009","journal-title":"N Engl J Med"},{"issue":"6","key":"2019111905014812700_B18","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.jaci.2011.03.004","article-title":"In vivo T-cell dynamics during immune reconstitution after hematopoietic stem cell gene therapy in adenosine deaminase severe combined immune deficiency.","volume":"127","author":"Selleri","year":"2011","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"2019111905014812700_B19","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.bbmt.2008.11.022","article-title":"Association between busulfan exposure and outcome in children receiving intravenous busulfan before hematologic stem cell transplantation.","volume":"15","author":"Bartelink","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"2019111905014812700_B20"},{"issue":"11","key":"2019111905014812700_B21","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1373\/clinchem.2003.021576","article-title":"Capillary electrophoresis in diagnosis and monitoring of adenosine deaminase deficiency.","volume":"49","author":"Carlucci","year":"2003","journal-title":"Clin Chem"},{"issue":"6","key":"2019111905014812700_B22","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1172\/JCI110389","article-title":"Bone marrow transplantation only partially restores purine metabolites to normal in adenosine deaminase-deficient patients.","volume":"68","author":"Hirschhorn","year":"1981","journal-title":"J Clin Invest"},{"issue":"1","key":"2019111905014812700_B23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1067\/mpd.2001.115023","article-title":"Cognitive and behavioral abnormalities in adenosine deaminase deficient severe combined immunodeficiency.","volume":"139","author":"Rogers","year":"2001","journal-title":"J Pediatr"},{"issue":"5","key":"2019111905014812700_B24","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1182\/blood.V80.5.1163.1163","article-title":"Antibody responses to bacteriophage phi X174 in patients with adenosine deaminase deficiency.","volume":"80","author":"Ochs","year":"1992","journal-title":"Blood"},{"issue":"2","key":"2019111905014812700_B25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.clim.2006.12.009","article-title":"Management options for adenosine deaminase deficiency; proceedings of the EBMT satellite workshop (Hamburg, March 2006).","volume":"123","author":"Booth","year":"2007","journal-title":"Clin Immunol"},{"issue":"3","key":"2019111905014812700_B26","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0022-3476(97)70200-2","article-title":"Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations.","volume":"130","author":"Comans-Bitter","year":"1997","journal-title":"J Pediatr"},{"issue":"5","key":"2019111905014812700_B27","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jaci.2003.07.003","article-title":"Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study.","volume":"112","author":"Shearer","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"2019111905014812700_B28","author":"Kruisbeek"},{"issue":"6148","key":"2019111905014812700_B29","doi-asserted-by":"crossref","first-page":"1233151","DOI":"10.1126\/science.1233151","article-title":"Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome.","volume":"341","author":"Aiuti","year":"2013","journal-title":"Science"},{"key":"2019111905014812700_B30","volume-title":"WHO Child Growth Standards: Length\/Height-for-Age, Weight-for-Age, Weight-for-Length, Weight-for-Height and Body Mass Index-for-Age: Methods and Development","author":"WHO Multicentre Growth Reference Study Group","year":"2006"},{"key":"2019111905014812700_B31","volume-title":"WHO Child Growth Standards: Head Circumference-for-Age, Arm Circumference-for-Age, Triceps Skinfold-for-Age, and Subscapular Skinfold-for-Age: Methods And Development","author":"WHO Multicentre Growth Reference Study Group","year":"2007"},{"issue":"4","key":"2019111905014812700_B32","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/(SICI)1097-0258(19980228)17:4<407::AID-SIM742>3.0.CO;2-L","article-title":"British 1990 growth reference centiles for weight, height, body mass index and head circumference fitted by maximum penalized likelihood.","volume":"17","author":"Cole","year":"1998","journal-title":"Stat Med"},{"issue":"3","key":"2019111905014812700_B33","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jaci.2013.12.1043","article-title":"B-cell development and functions and therapeutic options in adenosine deaminase-deficient patients.","volume":"133","author":"Brigida","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"2019111905014812700_B34","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nm0798-775","article-title":"T lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates.","volume":"4","author":"Kohn","year":"1998","journal-title":"Nat Med"},{"issue":"2","key":"2019111905014812700_B35","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.iac.2010.01.002","article-title":"Bone marrow transplantation and alternatives for adenosine deaminase deficiency.","volume":"30","author":"Gaspar","year":"2010","journal-title":"Immunol Allergy Clin North Am"},{"issue":"4","key":"2019111905014812700_B36","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/fampra\/cmi035","article-title":"The prevalence of symptoms and consultations in pre-school children in the Avon Longitudinal Study of Parents and Children (ALSPAC): a prospective cohort study.","volume":"22","author":"Hay","year":"2005","journal-title":"Fam Pract"},{"issue":"6","key":"2019111905014812700_B37","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.jaci.2011.04.014","article-title":"Purine metabolism, immune reconstitution, and abdominal adipose tumor after gene therapy for adenosine deaminase deficiency.","volume":"127","author":"Grunebaum","year":"2011","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"2019111905014812700_B38","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/emmm.201000108","article-title":"Integration profile of retroviral vector in gene therapy treated patients is cell-specific according to gene expression and chromatin conformation of target cell.","volume":"3","author":"Biasco","year":"2011","journal-title":"EMBO Mol Med"},{"issue":"97","key":"2019111905014812700_B39","doi-asserted-by":"crossref","first-page":"97ra80","DOI":"10.1126\/scitranslmed.3002716","article-title":"Hematopoietic stem cell gene therapy for adenosine deaminase-deficient severe combined immunodeficiency leads to long-term immunological recovery and metabolic correction.","volume":"3","author":"Gaspar","year":"2011","journal-title":"Sci Transl Med"},{"issue":"8","key":"2019111905014812700_B40","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1182\/blood-2006-07-034678","article-title":"Patients with adenosine deaminase deficiency surviving after hematopoietic stem cell transplantation are at high risk of CNS complications.","volume":"109","author":"H\u00f6nig","year":"2007","journal-title":"Blood"},{"issue":"5","key":"2019111905014812700_B41","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1056\/NEJMoa1401177","article-title":"Transplantation outcomes for severe combined immunodeficiency, 2000-2009.","volume":"371","author":"Pai","year":"2014","journal-title":"N Engl J Med"},{"issue":"1","key":"2019111905014812700_B42","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s10875-012-9797-6","article-title":"Post-transplantation B cell function in different molecular types of SCID.","volume":"33","author":"Buckley","year":"2013","journal-title":"J Clin Immunol"},{"issue":"4","key":"2019111905014812700_B43","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1089\/hum.2015.047","article-title":"Clinical applications of gene therapy for primary immunodeficiencies.","volume":"26","author":"Cicalese","year":"2015","journal-title":"Hum Gene Ther"},{"issue":"5","key":"2019111905014812700_B44","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.coi.2012.08.008","article-title":"Gene therapy for primary immunodeficiencies: part 1.","volume":"24","author":"Cavazzana-Calvo","year":"2012","journal-title":"Curr Opin Immunol"},{"issue":"5","key":"2019111905014812700_B45","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.coi.2012.07.012","article-title":"Gene therapy for primary immunodeficiencies: Part 2.","volume":"24","author":"Aiuti","year":"2012","journal-title":"Curr Opin Immunol"},{"issue":"4","key":"2019111905014812700_B46","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2174\/1566523215666150515145255","article-title":"Successful combination of sequential gene therapy and rescue allo-HSCT in two children with X-CGD\u2014importance of timing.","volume":"15","author":"Siler","year":"2015","journal-title":"Curr Gene Ther"},{"issue":"1","key":"2019111905014812700_B47","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/mt.2010.232","article-title":"Gene therapy of chronic granulomatous disease: the engraftment dilemma.","volume":"19","author":"Grez","year":"2011","journal-title":"Mol Ther"},{"issue":"227","key":"2019111905014812700_B48","doi-asserted-by":"crossref","first-page":"227ra33","DOI":"10.1126\/scitranslmed.3007280","article-title":"Gene therapy for Wiskott-Aldrich syndrome: long-term efficacy and genotoxicity.","volume":"6","author":"Braun","year":"2014","journal-title":"Sci Transl Med"},{"issue":"18","key":"2019111905014812700_B49","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1182\/blood-2012-02-400937","article-title":"Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans.","volume":"120","author":"Candotti","year":"2012","journal-title":"Blood"},{"issue":"2","key":"2019111905014812700_B50","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.gene.2013.03.098","article-title":"Gene therapy for PIDs: progress, pitfalls and prospects.","volume":"525","author":"Mukherjee","year":"2013","journal-title":"Gene"},{"issue":"3","key":"2019111905014812700_B51","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2174\/1566523211313030006","article-title":"Insertional mutagenesis by retroviral vectors: current concepts and methods of analysis.","volume":"13","author":"Knight","year":"2013","journal-title":"Curr Gene Ther"},{"issue":"8","key":"2019111905014812700_B52","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1172\/JCI31666","article-title":"Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy.","volume":"117","author":"Aiuti","year":"2007","journal-title":"J Clin Invest"},{"issue":"5","key":"2019111905014812700_B53","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1172\/JCI115761","article-title":"IgG antibody response to polyethylene glycol-modified adenosine deaminase in patients with adenosine deaminase deficiency.","volume":"89","author":"Chaffee","year":"1992","journal-title":"J Clin Invest"},{"issue":"6","key":"2019111905014812700_B54","first-page":"462","article-title":"Suppression of an antibody to adenosine-deaminase (ADA) in an ADA-deficient patient receiving polyethylene glycol modified adenosine deaminase.","volume":"70","author":"Chun","year":"1993","journal-title":"Ann Allergy"},{"issue":"7","key":"2019111905014812700_B55","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1128\/CDLI.12.7.861-866.2005","article-title":"polyethylene glycol-conjugated adenosine deaminase (ADA) therapy provides temporary immune reconstitution to a child with delayed-onset ADA deficiency.","volume":"12","author":"Lainka","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"2019111905014812700_B56","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3389\/fimmu.2012.00265","article-title":"Autoimmune dysregulation and purine metabolism in adenosine deaminase deficiency.","volume":"3","author":"Sauer","year":"2012","journal-title":"Front Immunol"},{"issue":"7","key":"2019111905014812700_B57","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/archdischild-2014-306425","article-title":"Severe combined immunodeficiency: recent developments and guidance on clinical management.","volume":"100","author":"Rivers","year":"2015","journal-title":"Arch Dis Child"},{"key":"2019111905014812700_B58","author":"Gaspar"}],"updated-by":[{"DOI":"10.1182\/blood-2017-05-782862","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,6,15]],"date-time":"2017-06-15T00:00:00Z","timestamp":1497484800000}}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/128\/1\/45\/1395155\/45.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/128\/1\/45\/1395155\/45.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T08:13:24Z","timestamp":1600503204000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/128\/1\/45\/35346\/Update-on-the-safety-and-efficacy-of-retroviral"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,7]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,7,7]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2016-01-688226","relation":{"erratum":[{"id-type":"doi","id":"10.1182\/blood-2017-05-782862","asserted-by":"object"}]},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,7]]}}}